Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination? — CFSMEATLAS
Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?
Ryabkova, Varvara A, Churilov, Leonid P, Shoenfeld, Yehuda · International journal of molecular sciences · 2019 · DOI
Quick Summary
This review explores three interconnected biological processes that may cause fibromyalgia and chronic fatigue syndrome (ME/CFS): the immune system attacking the body's own tissues, inflammation in the nervous system, and damage to small nerve fibers. The authors propose that these three mechanisms work together and may explain why patients experience widespread pain, extreme fatigue, and other symptoms like brain fog and sleep problems. They also examine whether similar mechanisms might explain some adverse reactions to HPV vaccination.
Why It Matters
Understanding how autoimmunity, neuroinflammation, and nerve fiber damage interact could help researchers develop more targeted treatments for ME/CFS and fibromyalgia. This framework may explain why current treatments often work only partially and could guide the search for therapies addressing the underlying biological mechanisms rather than just symptoms. For patients, clarifying these mechanisms validates the biological basis of their condition beyond psychological explanations.
Observed Findings
Autoimmunity, neuroinflammation, and small fiber neuropathy are documented in both fibromyalgia and ME/CFS populations
These three mechanisms share overlapping molecular pathways and may reinforce each other
Dysautonomia (nervous system dysregulation) is a common feature in both conditions
Small fiber neuropathy is detected in subsets of fibromyalgia and ME/CFS patients
Neuroinflammatory markers have been identified in some adverse events following HPV vaccination
Inferred Conclusions
A integrated neuroimmunological model incorporating autoimmunity, neuroinflammation, and SFN may better explain fibromyalgia and ME/CFS pathogenesis than single-mechanism explanations
The hypothalamus may be a key target organ in ME/CFS, supporting an 'autoimmune hypothalamopathy' concept
Treatment strategies should consider the interconnected nature of these mechanisms rather than targeting them in isolation
Neuroinflammation may represent a common downstream pathway relevant to understanding adverse vaccine responses and disease pathogenesis
Remaining Questions
Which patients with ME/CFS and fibromyalgia have which mechanism(s) predominantly, and are there biomarkers to stratify subtypes?
What This Study Does Not Prove
This review does not establish causation—it synthesizes existing research without presenting new experimental data. It does not prove that all ME/CFS or fibromyalgia cases involve autoimmunity or small fiber neuropathy equally. The proposed link between HPV vaccination and neuroinflammation in these conditions remains controversial and is not definitively established by this analysis.
Can clinical trials demonstrate that treatments targeting autoimmunity, neuroinflammation, or SFN improve outcomes in ME/CFS?
What is the temporal relationship between these three mechanisms—does one initiate the others?
How do genetic and environmental factors determine whether HPV vaccination or other triggers lead to these neuroimmunological responses in susceptible individuals?